Pular para o conteúdo principal

User account menu

  • Entrar

Idiomas

  • English
  • Français
  • Português
  • Español
  • العربية
  • Pусский

Navegação principal

  • Sobre o ISSUP

    • Fundamentação do ISSUP
    • Associação
      • Como se tornar um membro
      • Código de Ética
      • Who is ISSUP for?
    • Notícias
    • Parceiros Internacionais
    • Governança
    • ISSUP Scientific Council
    • Friends of ISSUP (USA)
    • ISSUP Workshops
      • Bali 2025
      • Thessaloniki 2024
      • Buenos Aires 2023
      • Manila 2022
      • Abu Dhabi 2022
      • International Conference 2021 (Virtual)
      • Africa 2020 (Virtual)
      • Viena 2019
      • Nairobi 2018
      • Cancún 2017
      • ISSUP Campinas 2016
      • ISSUP Tailandia 2015
    • Prémio ISSUP
      • Prémio Baseado em Evidências
      • Prémio de Iniciativa Local
      • Prémio de Serviços
      • Excellence in Training Provision
      • Outstanding Contribution to ISSUP Award
    • In Memoriam
    • Acknowledgements
    • Guias do site da ISSUP
    • Contate o ISSUP
    • FAQs - Frequently Asked Questions
  • Treinamento

    • Online Learning Hub
      • How to Register
      • UTC Self Led Courses
    • Universal Curricula (UC)
      • Currículo de Prevenção Universal
      • Currículo de Tratamento Universal
      • Universal Recovery Curriculum
      • Aceder UPC & UTC
      • Provedores de Formação
      • Tornar-se um Provedor de Formação
    • Resources
      • Glossary
      • ISSUP Webinars
      • ICAP certification
      • INEP Plus
      • Prevention Insights Video Series
      • Prevention Lists
      • HealthEKnowledge
      • WiRED International
      • Quality in Treatment
      • Manual de Investigação em Prevenção SPR-ISSUP
    • Job Board
  • Knowledge Share

    • Search in the Knowledge Share
    • ADDICTOLOGY Journal
      • Latest Issue
  • Comitês Nacionais

    • Africa
      • ISSUP Botswana
      • ISSUP Côte d’Ivoire
      • ISSUP Egypt
      • ISSUP The Gambia
      • ISSUP Kenya
      • ISSUP Namibia
      • ISSUP Nigeria
      • ISSUP South Africa
      • ISSUP Tanzania
      • ISSUP Togo
      • ISSUP Uganda
    • The Americas
      • ISSUP Argentina
      • ISSUP The Bahamas
      • ISSUP Brazil
      • ISSUP Canada
      • ISSUP Chile
      • ISSUP Colombia
      • ISSUP Ecuador
      • ISSUP El Salvador
      • ISSUP Guatemala
      • ISSUP Mexico
      • ISSUP Panama
      • ISSUP Paraguay
      • ISSUP Peru
      • ISSUP United States
    • Asia
      • ISSUP Afghanistan
      • ISSUP India
      • ISSUP Indonesia
      • ISSUP Kazakhstan
      • ISSUP Lebanon
      • ISSUP Malaysia
      • ISSUP in Pakistan
      • ISSUP Philippines
      • ISSUP Qatar
      • ISSUP Sri Lanka
      • ISSUP Thailand
      • ISSUP Türkiye
      • ISSUP United Arab Emirates
      • ISSUP Uzbekistan
      • ISSUP Vietnam
    • Europe
      • ISSUP Czech Republic
      • ISSUP Greece
      • ISSUP Italy
      • ISSUP Spain
      • ISSUP Ukraine
      • ISSUP United Kingdom
    • How to Become a National Chapter
    • ISSUP National Chapters' Advisory Committee
  • Events

    • Search through all events
  • Fórum

    • A–Z
  • My ISSUP

    • Member Directory
    • Candidate-se para adesão

Workplace-based Prevention

DiscussionsArquivosImagensVideosLinksEventosKnowledge ShareTudo
Karen Belanger

The Workplace and Prevention of Opioid Deaths

Karen Belanger - 3 August 2020

 

For many years it has been a theory among some in the substance abuse prevention field that inclusion of the workplace in community prevention efforts has been a “missing link.” A recent essay published this month in the American Journal of Public Health, entitled, Work Environment Factors and Prevention of Opioid–Related Deaths, lends further credence to that assumption, stating the authors’ belief that “this is a critical gap in prevention efforts.”

 

The article outlined a number of studies relating opioid overdose deaths preceded by workplace–related injuries and opioid use. One U.S...

  • Leia mais sobre The Workplace and Prevention of Opioid Deaths
  • Comentar
Karen Belanger

Pandemic Effects: The Opioid Crisis and the Workplace

Karen Belanger - 22 July 2020

 

The combined effects of COVID19 including the outcomes of contracting the disease itself, prolonged quarantine, isolation, fear of getting the virus, uncertainty of the future, hopelessness, grief over loss of a loved one, and general disruption, have negatively impacted many people’s mental health with anxiety, depression, and worse.  It has also caused some persons to turn to alcohol and drugs to cope, potentially affecting their workplace.  Whether people are still employed at their job site or at home, drug-free workplace programs continue to be important, now more than ever, to...

  • Leia mais sobre Pandemic Effects: The Opioid Crisis and the Workplace
  • Comentar
Karen Belanger

A Global Perspective on Workplace Drug Testing

Karen Belanger - 17 July 2020

 

Workplace drug testing around the world is quite varied and must address a number of regionally unique factors that affect the collection and processing of suitable test specimens.

 

There are a few challenges to international drug testing that may arise during the strict specimen collection and handling process.  It is extremely important to maintain the integrity of the testing protocol and the security of the specimens as they move through the collection and test analysis process.  This procedure, often called the “chain of custody,” protects the employee’s rights of accuracy. Some of...

  • Leia mais sobre A Global Perspective on Workplace Drug Testing
  • Comentar
Karen Belanger

Marijuana Trends and the Workplace

Karen Belanger - 14 July 2020
Person exhaling vapor after using a vape device

 

E-Cigarettes

You've seen them everywhere and may know someone who uses one. Electronic cigarettes, looking like regular cigarettes, have become the latest smoking-related trend. The slim e-cigarette holds liquid nicotine that, when heated into a vapor, can be inhaled. There is no smoke, only water vapor. The liquid nicotine, also known as e-liquids or e-juice, are trendy and hip; sold in some areas at "juice bars" and offered in fruity flavors such as strawberry, peach, and mango, among others.

In fact, they are becoming so popular that “Big Tobacco” has targeted young adults in their...

  • Leia mais sobre Marijuana Trends and the Workplace
  • Comentar
Karen Belanger

Drugs Impact the Bottom Line

Karen Belanger - 1 July 2020

Featured in Aqua Magazine  | Phillip M. Morris | May 2020

 

Drug problems for pool and spa businesses range in severity. There are many employees whose quiet consumption of recreational drugs in off-hours will never be noticed. But there are plenty of others who will make drug use part of their workday, compromising the quality of their work and the reputation of their employer.  

READ MORE(link is external)

 

 

  • Leia mais sobre Drugs Impact the Bottom Line
  • Comentar
Karen Belanger

Webinar Recording: Substance Use Prevention in the Workplace and Its Role in the Community

Karen Belanger - 20 June 2020

Hello!

 

Here is the link to the recording of our most recent webinar, Substance Use Prevention in the Workplace and Its Role in the Community, held 16 June 2020: 

 

https://www.ndwa.org/wp-content/uploads/2020/06/Webinar-Substance-Use-Prevention-in-the-Workplace-and-Its-Role-in-the-Community.mp4(link is external).

 

You may respond here if you have any questions.  Also, please stay tuned for announcements on future drug free workplace webinar events in the coming months.

 

 

 

 

  • Leia mais sobre Webinar Recording: Substance Use Prevention in the Workplace and Its Role in the Community
  • Comentar
Karen Belanger

Synthetic Drugs and the Impacts to the Workplace

Karen Belanger - 15 June 2020

 

Synthetic drugs, also referred to as designer drugs or club drugs, mimic the effects of illicit drugs such as marijuana, cocaine, LSD, opium, and ecstasy. They are often marketed as "legal highs" and are available over-the-counter at smoke shops and many neighborhood convenience stores.

 

Government authorities in many countries have banned certain chemicals used to manufacture these products and many of them have been added to the lists of controlled substances. Despite new laws banning the chemical compounds of these drugs, manufacturers of synthetic drugs stay one step ahead by...

  • Leia mais sobre Synthetic Drugs and the Impacts to the Workplace
  • Comentar
Karen Belanger

Substance Use and Mental Health Implications for the Workplace

Karen Belanger - 5 June 2020

 

As substance use and the availability of highly potent drugs increases globally, so too does comorbid substance use and mental health disorders.  According to the World Health Organization there was a 13% rise in mental health conditions and substance use disorders in the decade from 2007 to 2017.

 

Comorbidity is the occurrence of two or more disorders or illnesses within the same person either simultaneously or one following the other. Interactions between illnesses can exacerbate both. Comorbidity can be caused by a number of factors such as genetics, trauma, and adverse childhood...

  • Leia mais sobre Substance Use and Mental Health Implications for the Workplace
  • Comentar
Karen Belanger

Live Webinar -Substance Use Prevention in the Workplace and Its Role in the Community

Karen Belanger - 3 June 2020

 

Tuesday June 16, 2020

at 10:00 AM EDT

 

Calling All Workplace Stakeholders!

 

Drug Free America Foundation cordially invites you to participate in a webinar Tuesday June 16th on: Substance Use Prevention in the Workplace and Its Role in the Community 

 

Webinar Summary
Engaging young adults aged 18 – 25, parents and local businesses in meaningful and relevant ways sometimes challenges community prevention providers. The workplace provides an excellent venue to reach these populations in ways that promote the goals of a safe and healthy community, and for businesses a safe and...

  • Leia mais sobre Live Webinar -Substance Use Prevention in the Workplace and Its Role in the Community
  • Comentar
Karen Belanger

Employee Assistance Programs in the Workplace

Karen Belanger - 23 May 2020

An Employee Assistance Program, or EAP, allows organizations to offer help to employees with a work-based intervention program that helps workers to resolve a wide variety of personal problems, including problems with alcohol and drugs.   

The EAP assistance may be provided in a variety of ways that fits the needs of the employer. Some of the program types include: in-house programs, fee-per-person programs, pay-per-use programs, consortia programs, labor union-based assistance programs, or peer-assistance programs. While the cost of the EAP is generally covered by the employer, there are low...

  • Leia mais sobre Employee Assistance Programs in the Workplace
  • Comentar
Karen Belanger

Substance Use Prevention in the Workplace and Its Role in the Community

Karen Belanger - 15 May 2020

Live Webinar
Tuesday June 16, 2020 
at 10:00 AM EDT

Calling All Workplace Stakeholders!

Drug Free America Foundation cordially invites you to participate in a webinar Tuesday June 16th on: Substance Use Prevention in the Workplace and Its Role in the Community 


Webinar Summary
Engaging young adults aged 18 – 25, parents and local businesses in meaningful and relevant ways sometimes challenges community prevention providers. The workplace provides an excellent venue to reach these populations in ways that promote the goals of a safe and healthy community, and for businesses a safe and...

  • Leia mais sobre Substance Use Prevention in the Workplace and Its Role in the Community
  • Comentar
Karen Belanger

Webinar Recording - The Three I's: Impairment, Intoxication, and Under the Influence

Karen Belanger - 1 May 2020

Hello!

 

Here is a link to the recording of our most recent webinar, The Three I's: Impairment, Intoxication, and Under the Influence - How to Identify These in the Workplace, held 28 April 2020.  
 

https://www.ndwa.org/wp-content/uploads/2020/04/Webinar-How-to-Identify-Impairment-Intoxication-Under-the-Influence-in-the-Workplace-1.mp4(link is external)

 

You may respond here if you have any questions.  Also, please stay tuned for announcements on future drug free workplace webinar events in the coming months.

  • Leia mais sobre Webinar Recording - The Three I's: Impairment, Intoxication, and Under the Influence
  • Comentar
Karen Belanger

Communicating with Employees About Your Drug-Free Workplace

Karen Belanger - 30 April 2020

 

Good communication with your employees is an essential function in all workplaces, and extremely important when dealing with the company’s drug-free workplace program. When working with employees, supervisors must be aware of potential employment–related legal issues and practice standards.  When the interaction includes discussions of substance use, the supervisor must also be aware of and understand the disease nature of substance use, substance use disorders, and addiction.

 

Supervisors should prepare ahead by ensuring they have followed all the required steps of the drug-free...

  • Leia mais sobre Communicating with Employees About Your Drug-Free Workplace
  • Comentar
Karen Belanger

April is Alcohol Awareness Month

Karen Belanger - 22 April 2020

Alcohol Use and Its Effects on the Workplace

 

As one of the most commonly used substances, the effects of alcohol use by employees can have a big impact to the workplace.  Absenteeism, job turnover, accidents and injuries, increased insurance costs, theft, and increased training costs are all some of the negative effects that result from the use of alcohol and other drugs in the work environment.

 

Employers can encourage and positively influence workers to consider the amount of alcohol they consume and individually adopt strategies to reduce their drinking and make healthy changes to...

  • Leia mais sobre April is Alcohol Awareness Month
  • Comentar
Karen Belanger

Documenting Reasonable Suspicion of Substance Use in the Workplace

Karen Belanger - 16 April 2020

 

As a manager, knowing the steps to take to properly document situations such as the reasonable suspicion of substance use is of paramount importance. This documentation, along with the results of drug and alcohol testing, provide the basis for potential serious employment action in accordance with company policy.  The resulting steps may include but are not limited to the following referral programs: Employee Assistance Program (EAP), medical and/or substance use evaluation and treatment, or other appropriate resources in the area.

 

It is imperative that supervisors and managers are...

  • Leia mais sobre Documenting Reasonable Suspicion of Substance Use in the Workplace
  • 1 comentário
  • Comentar
Karen Belanger

Celebrating World Health Day with a Safe and Healthy Workplace

Karen Belanger - 6 April 2020

Although the World Health Organization (WHO) is rightfully focusing its 2020 World Health Day promotion on nurses and midwives, we wish to promote the universal importance of health and safety in the workplace especially related to the dangers of substance use.

 

In a 2013 report, the International Labour Organization estimated that globally there are more than 3 billion workers (International Labour Organization, 2013). WHO stated that employees spend an average of one-third of their lives generating the products and services of their countries, however, 15.8% of occupational risks to...

  • Leia mais sobre Celebrating World Health Day with a Safe and Healthy Workplace
  • Comentar
Karen Belanger

Performance Indicators of Potential Substance Use

Karen Belanger - 30 March 2020

Most employers strive to provide a safe and healthy work environment as well as encourage their employees to have healthy lifestyles.  They consider the use of drugs and alcohol on the job to be an unsafe counter‑productive work practice and a serious threat to all of their workers and the public. In consideration of this, most employers prohibit the use, of illegal drugs and alcohol at work.

 

While drug testing can indicate the presence of a drug, it does not indicate the level of impairment. Additionally, there are many impairing substances, such as designer drugs, or inhalants, that aren...

  • Leia mais sobre Performance Indicators of Potential Substance Use
  • Comentar
Karen Belanger

Considering Consequences for Employer Drug-Free Workplace Policy Violations

Karen Belanger - 23 March 2020

 

When creating a drug-free workplace policy, there are a number of key considerations that an employer must make.  Among those decisions may be: what drugs will be included, which employees will be included, and the behaviors to be included.  While the focus of a policy that prohibits certain behaviors can easily shift to a seemingly negative, punitive consequence, the emphasis of a drug-free workplace policy must remain on safety and health to make this a win-win for all stakeholders.

 

 

Considering the possible consequences for a violation to an employers’ drug-free workplace policy...

  • Leia mais sobre Considering Consequences for Employer Drug-Free Workplace Policy Violations
  • Comentar
Karen Belanger

Webinar Recording: The Impacts of Marijuana and Opioids on the Workplace - 26 Feb 2020

Karen Belanger - 27 February 2020

Hello!

 

Here is a link to the recording of our Impacts of Marijuana and Opioids on the Workplace Webinar held 26 February 2020.  
 

https://zoom.us/rec/share/4eAuMq7yyzJOT6vU5hz9Ga4sQqPVT6a8g3Ib8vdfxBmRr7ydyRqiyt1dTQacBF3n(link is external)

 

You may respond here if you have any questions.  Also, please stay tuned for announcements on future drug free workplace webinar events in the coming months.

  • Leia mais sobre Webinar Recording: The Impacts of Marijuana and Opioids on the Workplace - 26 Feb 2020
  • Comentar
Karen Belanger

Observed Issues Resulting from Drugs in the Workplace

Karen Belanger - 21 February 2020

Observed Workplace Issues – Indiana Business Survey

These data are from a survey of employers in the U.S. state of Indiana.  The employers were asked to identify which problems they experienced in their workplaces. Respondents could check all that apply.

 

Employers who observed a substance misuse issue - 80%

The substance misuse issues identified by the employers were as follows:

  1. Use of Rx painkillers at work - 59%
  2. Positive drug tests for prescription - 41%
  3. Absenteeism or missed work - 41%
  4. Family member affected - 40%
  5. Impaired/decreased job performance - 35%
  6. Borrowing or selling...
  • Leia mais sobre Observed Issues Resulting from Drugs in the Workplace
  • Comentar

Paginação

  • Primeira página « First
  • Página anterior ‹‹
  • …
  • Página 5
  • Página 6
  • Página 7
  • Página 8
  • Página atual 9
  • Página 10
  • Próxima página ››
  • Última página Last »

Upcoming Events

There aren't any upcoming events
All Events
Contate-nos

Stay Connected

Newsletter

ISSUP is funded by the U.S. Department of State via the Bureau of International Narcotics and Law Enforcement Affairs (INL). INL works to keep Americans safe by countering crime, illegal drugs, and instability abroad.

Copyright © International Society of Substance Use Prevention and Treatment Professionals Privacy Policy (link is external)